CIK 0001500198 · Non-accelerated filer<br>Smaller reporting company
NEUROONE MEDICAL TECHNOLOGIES Corp
Sign in to watch- Ticker
- NMTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270863354
- Phone
- (952) 426-1383
- Business address
- 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
- Former names
- Original Source Entertainment, Inc.
- Open-market buys, last 90 days
- $66,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$66,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Wambeke David J. Chief Business Officer | Grant or award · Option to Purchase Common Stock | +35,000 | 35,000 | ||
| 2026-08-28 | Johns Emily J. Chief Administrative Officer | Grant or award · Option to Purchase Common Stock | +12,500 | 12,500 | ||
| 2026-08-28 | Volker Christopher Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +35,000 | 35,000 | ||
| 2026-08-28 | Mertens Steve Chief Technology Officer | Grant or award · Option to Purchase Common Stock | +15,000 | 15,000 | ||
| 2026-08-28 | Christianson Mark Market Development Director | Grant or award · Option to Purchase Common Stock | +12,500 | 12,500 | ||
| 2026-08-28 | Rosa David A CEO & President | Grant or award · Option to Purchase Common Stock | +68,000 | 68,000 | ||
| 2026-08-27 | Wambeke David J. Chief Business Officer | Purchase | +33,333 | $2.01 | $67K | 199,999 |
| 2026-06-30 | Christianson Mark Market Development Director | Sale | −10,000 | $3.18 | $32K | 20,692 |
| 2026-04-03 | Mills Jason Richard Director | Grant or award | +41,929 | 49,687 | ||
| 2026-04-03 | Mills Jason Richard Director | Grant or award · Option to Purchase Common Stock | +26,036 | 26,036 | ||
| 2026-04-03 | Andrle Edward Director | Grant or award | +41,929 | 133,932 | ||
| 2026-04-03 | Andrle Edward Director | Grant or award · Option to Purchase Common Stock | +26,036 | 26,036 | ||
| 2026-04-03 | MATHIESEN JEFFREY S Director | Grant or award | +41,929 | 156,343 | ||
| 2026-04-03 | MATHIESEN JEFFREY S Director | Grant or award · Option to Purchase Common Stock | +26,036 | 26,036 | ||
| 2026-04-03 | BUCKMAN PAUL Director | Grant or award | +41,929 | 178,733 | ||
| 2026-04-03 | BUCKMAN PAUL Director | Grant or award · Option to Purchase Common Stock | +26,036 | 26,036 | ||
| 2026-03-31 | Mertens Steve Chief Technology Officer | Shares withheld for taxes | −906 | $0.78 | $704 | 152,141 |
| 2026-03-31 | Christianson Mark Business Development Director | Shares withheld for taxes | −253 | $0.78 | $197 | 198,667 |
| 2026-03-31 | Rosa David A CEO and President | Shares withheld for taxes | −2,458 | $0.78 | $2K | 1,080,132 |
| 2026-03-30 | Christianson Mark Business Development Director | Sale | −15,363 | $0.74 | $11K | 198,920 |
Page 1 of 6 · 116 trades